New combined treatment shows promise in hepatocellular carcinoma
Researchers from the Metabolism and Cancer group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Kozma, have unveiled a new potential combined treatment for hepatocellular carcinoma (HCC), the second ...